Stockscreener 앱 받기
27.14
1.20%
-0.33
시간 외 거래:
27.14
전일 마감가:
$27.47
열려 있는:
$28
하루 거래량:
305.42K
Relative Volume:
0.70
시가총액:
$1.47B
수익:
$2.22M
순이익/손실:
$-40.51M
주가수익비율:
-21.13
EPS:
-1.2847
순현금흐름:
$-46.53M
1주 성능:
-2.20%
1개월 성능:
+14.42%
6개월 성능:
+134.78%
1년 성능:
+32.97%
1일 변동 폭
$26.78
$28.25
1주일 범위
$26.78
$29.55
52주 변동 폭
$5.14
$33.00
Upstream Bio Inc Stock (UPB) Company Profile
명칭
Upstream Bio Inc
전화
781-208-2466
주소
890 WINTER STREET, SUITE 200, WALTHAM
UPB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UPB
Upstream Bio Inc
|
27.14 | 1.48B | 2.22M | -40.51M | -46.53M | -1.2847 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Upstream Bio Inc Stock (UPB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 개시 | Evercore ISI | Outperform |
| 2025-10-14 | 개시 | Truist | Buy |
| 2024-11-05 | 개시 | JP Morgan | Overweight |
| 2024-11-05 | 개시 | Piper Sandler | Overweight |
| 2024-11-05 | 개시 | TD Cowen | Buy |
| 2024-11-05 | 개시 | William Blair | Outperform |
모두보기
Upstream Bio Inc 주식(UPB)의 최신 뉴스
Financial Analysis: Precision BioSciences (NASDAQ:DTIL) & Upstream Bio (NASDAQ:UPB) - Defense World
Bain Capital Life Sciences Investors LLC Raises Holdings in Upstream Bio, Inc. $UPB - MarketBeat
Norges Bank Acquires New Position in Upstream Bio, Inc. $UPB - MarketBeat
Can Upstream Bio Stock Hold Up When Markets Turn? - Trefis
Contrasting Upstream Bio (UPB) & The Competition - Defense World
Geode Capital Management LLC Buys 235,958 Shares of Upstream Bio, Inc. $UPB - MarketBeat
Lifesci Capital Predicts Upstream Bio FY2025 Earnings - Defense World
Upstream Bio: Maintaining Buy Rating On Verekitug Success In Phase 2 CRSwNP Study (UPB) - Seeking Alpha
UPB: Virectib's robust phase 2 results and unique mechanism set the stage for pivotal trials in 2026 - TradingView
Lifesci Capital Forecasts Upstream Bio FY2025 Earnings - MarketBeat
Upstream Bio (NASDAQ:UPB) Shares Down 8%Here's What Happened - MarketBeat
Stocks of Upstream Bio Inc (UPB) are poised to climb above their peers - setenews.com
Upstream Bio (NASDAQ:UPB) Coverage Initiated by Analysts at Lifesci Capital - MarketBeat
Upstream Bio (NASDAQ:UPB) Now Covered by Analysts at Lifesci Capital - Defense World
LifeSci Capital Initiates Coverage of Upstream Bio (UPB) with Outperform Recommendation - Nasdaq
Upstream Bio initiated with an Outperform at LifeSci Capital - TipRanks
Is Upstream Bio Inc. stock attractive for ETFsJuly 2025 Snapshot & Fast Moving Stock Watchlists - Newser
What analysts say about Upstream Bio Inc stockEarnings Miss Alerts & Free High Yield Market Plays - earlytimes.in
Why retail investors favor Upstream Bio Inc. stockJuly 2025 Highlights & Detailed Earnings Play Alerts - BỘ NỘI VỤ
Severe Asthma Clinical Pipeline 2025: A Comprehensive Review of 50+ Emerging Therapies from 40+ Innovators, says DelveInsight - Barchart.com
You might want to take a look at Upstream Bio Inc (UPB) now - Setenews
Upstream Bio (NASDAQ:UPB) Shares Up 8.5%Should You Buy? - MarketBeat
Upstream Bio (UPB): Evaluating Valuation After 10% Share Price Surge - Yahoo Finance
Promising Outlook for Upstream Bio, Inc. Driven by Verekitug’s Clinical Advancements - TipRanks
Upstream Bio to Participate in Upcoming December Investor Conferences - The Manila Times
Upstream Bio stock reaches 52-week high at 26.99 USD By Investing.com - Investing.com Canada
Upstream Bio stock reaches 52-week high at 26.99 USD - Investing.com India
Commit To Buy Upstream Bio At $20, Earn 80.2% Annualized Using Options - Nasdaq
Why Upstream Bio Inc. stock is popular among millennialsEarnings Trend Report & Free Low Drawdown Momentum Trade Ideas - newser.com
How strong is Upstream Bio Inc. stock revenue growthEarnings Miss & Stock Portfolio Risk Management - newser.com
What risks investors should watch in Upstream Bio Inc. stock2025 Volatility Report & Growth-Oriented Investment Plans - newser.com
Using data filters to optimize entry into Upstream Bio Inc.Earnings Recap Summary & Daily Stock Momentum Reports - newser.com
Top investors say Upstream Bio Inc (UPB) ticks everything they need - Setenews
Evercore ISI Begins Coverage on Upstream Bio (NASDAQ:UPB) - MarketBeat
Upstream Bio (NASDAQ:UPB) Now Covered by Evercore ISI - Defense World
Upstream Bioprocessing Market on Track for Strong Growth, Estimated to Grow at 12.4% CAGR Through 2029 - openPR.com
Analyzing Upstream Bio Inc. with multi timeframe chartsTrade Entry Report & Risk Adjusted Swing Trade Ideas - newser.com
Upstream Bio, Inc.Common Stock (NQ: UPB - FinancialContent
Evercore ISI Group Initiates Coverage of Upstream Bio (UPB) with Outperform Recommendation - Nasdaq
Upstream Bio initiated with an Outperform at Evercore ISI - MSN
Upstream Bio, Inc.’s Verekitug: A Promising Buy with Blockbuster Potential in Asthma and COPD Markets - TipRanks
Why hedge funds are buying Upstream Bio Inc. stockTrade Analysis Summary & Verified Entry Point Detection - newser.com
What earnings revisions data tells us about Upstream Bio Inc.2025 Price Momentum & Community Driven Trade Alerts - newser.com
Ranking Upstream Bio Inc. among high performing stocks via toolsJuly 2025 Rallies & Daily Price Action Insights - newser.com
Can momentum traders help lift Upstream Bio Inc.Earnings Risk Summary & Smart Investment Allocation Insights - newser.com
Is Upstream Bio Inc. stock trading at a premium valuationEarnings Risk Summary & Smart Swing Trading Alerts - newser.com
Can Upstream Bio Inc. stock resist sector downturnsShort Setup & Real-Time Volume Triggers - newser.com
Candlestick signals on Upstream Bio Inc. stock todayPortfolio Gains Summary & Fast Exit Strategy with Risk Control - newser.com
Upstream Bio Inc (UPB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):